[HTML][HTML] Fanconi anemia pathway in colorectal cancer: A novel opportunity for diagnosis, prognosis and therapy
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour… - Journal of …, 2022 - search.proquest.com
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
[引用][C] 1. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa - spandidos-publications.com
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.
FG Parsa, S Nobili, M Karimpour… - Journal of …, 2022 - europepmc.org
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
[HTML][HTML] Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour… - Journal of …, 2022 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
[PDF][PDF] Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour… - J. Pers …, 2022 - pdfs.semanticscholar.org
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
[PDF][PDF] Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour, HA Aghdaei… - J. Pers. Med, 2022 - academia.edu
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.
FG Parsa, S Nobili, M Karimpour… - Journal of …, 2022 - search.ebscohost.com
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour, HA Aghdaei… - JOURNAL OF …, 2022 - flore.unifi.it
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy
FG Parsa, S Nobili, M Karimpour… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …